These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22216391)

  • 1. Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml.
    Chang JS; Choi H; Chang YS; Kim JB; Oh MM; Moon du G; Bae JH; Cheon J
    Korean J Urol; 2011 Dec; 52(12):809-14. PubMed ID: 22216391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy.
    Presti JC; Hricak H; Shinohara K; Carroll PR
    Urol Oncol; 1996; 2(6):177-83. PubMed ID: 21224166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor.
    Vives Dilme R; Rivas JG; Fernández Hernández L; De la Parra Sánchez I; Sánchez Del Hoyo R; Galante Romo MI; Redondo González E; Senovilla Pérez JL; Fernández Montarroso L; Moreno Sierra J
    Ther Adv Urol; 2024; 16():17562872241229250. PubMed ID: 38333072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Modified Partın Table to Better Predict Extracapsular Extensıon in Clinically Localized Prostate Cancer.
    Merder E; Arıman A; Altunrende F
    Urol J; 2021 Feb; 18(1):74-80. PubMed ID: 33550581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer.
    Ravery V; Chastang C; Toublanc M; Boccon-Gibod L; Delmas V; Boccon-Gibod L
    Eur Urol; 2000 Apr; 37(4):449-55. PubMed ID: 10765076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of extraprostatic extension in patients with clinically organ-confined prostate cancer.
    Lin S; Zhang Q; Li P; Li Z; Sun Y; Shao Y; Zhang X; Fu S
    Urol Int; 2014; 92(3):282-8. PubMed ID: 24280781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative prediction of extracapsular tumor extension at radical retropubic prostatectomy in Taiwanese patients with T1c prostate cancer.
    Ou YC; Chen JT; Yang CR; Cheng CL; Ho HC; Kao YL; Ko JL; Hsieh YS
    Jpn J Clin Oncol; 2002 May; 32(5):172-6. PubMed ID: 12110644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.
    Ravery V; Boccon-Gibod LA; Dauge-Geffroy MC; Billebaud T; Delmas V; Meulemans A; Toublanc M; Boccon-Gibod L
    Urology; 1994 Sep; 44(3):371-6. PubMed ID: 7521093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    J Clin Oncol; 1996 Jun; 14(6):1770-7. PubMed ID: 8656245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
    Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
    Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate weight: an independent predictor for positive surgical margins during robotic-assisted laparoscopic radical prostatectomy.
    Msezane LP; Gofrit ON; Lin S; Shalhav AL; Zagaja GP; Zorn KC
    Can J Urol; 2007 Oct; 14(5):3697-701. PubMed ID: 17949525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer.
    Brassell SA; Kao TC; Sun L; Moul JW
    Urology; 2005 Dec; 66(6):1229-33. PubMed ID: 16360448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer.
    Chen Y; Yu W; Fan Y; Zhou L; Yang Y; Wang H; Jiang Y; Wang X; Wu S; Jin J
    Oncotarget; 2017 Mar; 8(13):22095-22103. PubMed ID: 27564265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy.
    Ozgür A; Onol FF; Türkeri LN
    Int Urol Nephrol; 2004; 36(3):369-73. PubMed ID: 15783108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.